L. Sieve

Enoxaparin Prevents Progression of Stages I and II Osteonecrosis of the Hip

Charles J. Glueck, Richard A. Freiberg, L. Sieve et al. · Clinical Orthopaedics and Related Research · 2005 · 213 citations

Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia

Charles J. Glueck, D. Aregawi, Naila Goldenberg et al. · Journal of Laboratory and Clinical Medicine · 2005 · 109 citations

Thrombosis, Hypertension, Polycystic-ovary Syndrome +7

Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy

Charles J. Glueck, S. Dharashivkar, Ping Wang et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2005 · 98 citations

Obesity, Metabolic Syndrome, Health Sciences +11

Pregnancy Loss, Polycystic Ovary Syndrome, Thrombophilia, Hypofibrinolysis, Enoxaparin, Metformin

Charles J. Glueck, Ping Wang, Naila Goldenberg et al. · Clinical and Applied Thrombosis/Hemostasis · 2004 · 69 citations · Full text

Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome

Charles J. Glueck, L. Sieve, Binghua Zhu et al. · Metabolism · 2006 · 60 citations

Infertility, First-trimester Miscarriage, Genetics +7